home All News open_in_new Full Article
China’s SciNeuro, Novartis sign US$1.7 billion licensing deal to develop Alzheimer’s drugs
today 4 d. ago attach_file Economics
attach_file
Politics
attach_file
Politics
attach_file
Events
attach_file
Politics
attach_file
Society
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Politics
attach_file
Events
attach_file
Politics
attach_file
Politics
attach_file
Politics
ID: 1446736835